◆英語タイトル:Waters Corporation (WAT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011969
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月14日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, rheometry and calorimetry instruments. The company offers its solutions to pharmaceutical, biochemical, life sciences, industrial, academic and governmental institutions working in the areas of research and development, quality assurance and other laboratory applications Waters distributes its products primarily through its facilities located in Taunton, Massachusetts; Wilmslow, England; and Wexford, Ireland. Waters is headquartered in Milford, Massachusetts, the US.
Waters Corporation (WAT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Waters Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Waters Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Waters Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Waters Corporation, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Waters Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Waters Corporation, Medical Equipment, Deal Details 11
Asset Purchase 11
Waters Acquires REIMS Technology from MediMass 11
Partnerships 12
Sotax Enters into Licensing Agreement with Waters 12
Waters Enters Into Co-Development Agreement With Nonlinear Dynamics 13
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 14
Debt Offering 15
Waters Raises USD50 Million in Private Placement of Series I Notes Due 2023 15
Waters Raises USD40 Million in Private Placement of Series J Notes Due 2024 16
Waters Raises USD160 Million in Private Placement of Series K Notes Due 2026 17
Waters Completes Private Placement Of Series C Senior Notes Due 2016 For US$50 Million 18
Waters Completes Private Placement Of Series D Senior Notes Due 2018 For US$100 Million 19
Waters Completes Private Placement Of Series E Senior Notes Due 2021 For US$50 Million 20
Acquisition 21
Waters Acquires Nonlinear Dynamics From The Angel CoFund 21
Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For US$14 Million 22
Waters Corporation – Key Competitors 23
Waters Corporation – Key Employees 24
Waters Corporation – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 27
Strategy And Business Planning 27
Feb 16, 2016: Waters’ Centers of Innovation Program Recognizes Forensic Chemistry Laboratory at the University of Copenhagen 27
Financial Announcements 28
Oct 24, 2017: Waters Reports Third Quarter 2017 28
Jul 25, 2017: Waters Reports Second Quarter 2017 Financial Results 29
Apr 25, 2017: Waters Reports First Quarter 2017 Financial Results 30
Jan 24, 2017: Waters Reports Fourth Quarter and Full Year 2016 Financial Results 31
Oct 25, 2016: Waters Reports Third Quarter 2016 Financial Results 32
Jul 26, 2016: Waters Reports Second Quarter 2016 Financial Results 33
Apr 26, 2016: Waters Reports First Quarter 2016 Financial Results 34
Jan 26, 2016: Waters Reports Fourth Quarter and Full Year 2015 Financial Results 35
Corporate Communications 36
Jun 22, 2017: Waters Elects Flemming Ornskov to Board of Directors 36
Dec 08, 2016: Waters Announces Sherry Buck as Chief Financial Officer 37
Jan 25, 2016: Waters Corporation Expands Executive Team 38
Product News 39
Jun 08, 2017: Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil 39
Mar 06, 2017: Waters Introduces Cloud Deployable CDS, New Lines of Thermogravimetric Analyzers at Pittcon 2017 40
Feb 27, 2017: Waters Honors Singapore’s Bioprocessing Technology Institute (BTI) for Glycoscience Research 42
Other Significant Developments 43
Mar 15, 2017: Waters Now Offers Proteolabels Software 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
Waters Corporation, Medical Equipment, Key Facts, 2016 2
Waters Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Waters Corporation, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Waters Corporation, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Waters Corporation, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Waters Corporation, Deals By Market, 2011 to YTD 2017 9
Waters Corporation, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Waters Acquires REIMS Technology from MediMass 11
Sotax Enters into Licensing Agreement with Waters 12
Waters Enters Into Co-Development Agreement With Nonlinear Dynamics 13
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 14
Waters Raises USD50 Million in Private Placement of Series I Notes Due 2023 15
Waters Raises USD40 Million in Private Placement of Series J Notes Due 2024 16
Waters Raises USD160 Million in Private Placement of Series K Notes Due 2026 17
Waters Completes Private Placement Of Series C Senior Notes Due 2016 For US$50 Million 18
Waters Completes Private Placement Of Series D Senior Notes Due 2018 For US$100 Million 19
Waters Completes Private Placement Of Series E Senior Notes Due 2021 For US$50 Million 20
Waters Acquires Nonlinear Dynamics From The Angel CoFund 21
Waters Acquires Blue Reference, Maker Of Application Scientific Databases, For US$14 Million 22
Waters Corporation, Key Competitors 23
Waters Corporation, Key Employees 24
Waters Corporation, Subsidiaries 25